Literature DB >> 32542580

Purines: From Diagnostic Biomarkers to Therapeutic Agents in Brain Injury.

Bruno G Frenguelli1, Nicholas Dale2.   

Abstract

The purines constitute a family of inter-related compounds that serve a broad range of important intracellular and extracellular biological functions. In particular, adenosine triphosphate (ATP) and its metabolite and precursor, adenosine, regulate a wide variety of cellular and systems-level physiological processes extending from ATP acting as the cellular energy currency, to the adenosine arising from the depletion of cellular ATP and responding to reduce energy demand and hence to preserve ATP during times of metabolic stress. This inter-relationship provides opportunities for both the diagnosis of energy depletion during conditions such as stroke, and the replenishment of ATP after such events. In this review we address these opportunities and the broad potential of purines as diagnostics and restorative agents.

Entities:  

Keywords:  ATP; Adenine; Adenosine; Biomarker; Cerebral ischemia; D-ribose; Purines; Stroke; Traumatic brain injury

Mesh:

Substances:

Year:  2020        PMID: 32542580      PMCID: PMC7674544          DOI: 10.1007/s12264-020-00529-z

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  96 in total

1.  The composition of isolated cerebral tissue; purines.

Authors:  J THOMAS
Journal:  Biochem J       Date:  1957-08       Impact factor: 3.857

2.  Delayed production of adenosine underlies temporal modulation of swimming in frog embryo.

Authors:  N Dale
Journal:  J Physiol       Date:  1998-08-15       Impact factor: 5.182

3.  The adenosine metabolite inosine is a functional agonist of the adenosine A2A receptor with a unique signaling bias.

Authors:  Ajith A Welihinda; Manmeet Kaur; Kelly Greene; Yongjiao Zhai; Edward P Amento
Journal:  Cell Signal       Date:  2016-02-19       Impact factor: 4.315

Review 4.  Spreading depolarization is not an epiphenomenon but the principal mechanism of the cytotoxic edema in various gray matter structures of the brain during stroke.

Authors:  Jens P Dreier; Coline L Lemale; Vasilis Kola; Alon Friedman; Karl Schoknecht
Journal:  Neuropharmacology       Date:  2017-09-21       Impact factor: 5.250

Review 5.  Metabolic network of nucleosides in the brain.

Authors:  Piero L Ipata; Marcella Camici; Vanna Micheli; Maria G Tozz
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

Review 6.  Adenosine in the central nervous system: release mechanisms and extracellular concentrations.

Authors:  S Latini; F Pedata
Journal:  J Neurochem       Date:  2001-11       Impact factor: 5.372

7.  Restoring adenine nucleotides in a brain slice model of cerebral reperfusion.

Authors:  G C Newman; F E Hospod; S D Trowbridge; S Motwani; Y Liu
Journal:  J Cereb Blood Flow Metab       Date:  1998-06       Impact factor: 6.200

8.  Serum levels of glucose, insulin, and C-peptide during long-term D-ribose administration in man.

Authors:  M Gross; N Zöllner
Journal:  Klin Wochenschr       Date:  1991-01-04

9.  Spreading depolarization-induced adenosine accumulation reflects metabolic status in vitro and in vivo.

Authors:  Britta E Lindquist; C William Shuttleworth
Journal:  J Cereb Blood Flow Metab       Date:  2014-08-27       Impact factor: 6.200

10.  Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial.

Authors:  Michael D Hill; Mayank Goyal; Bijoy K Menon; Raul G Nogueira; Ryan A McTaggart; Andrew M Demchuk; Alexandre Y Poppe; Brian H Buck; Thalia S Field; Dar Dowlatshahi; Brian A van Adel; Richard H Swartz; Ruchir A Shah; Eric Sauvageau; Charlotte Zerna; Johanna M Ospel; Manish Joshi; Mohammed A Almekhlafi; Karla J Ryckborst; Mark W Lowerison; Kathy Heard; David Garman; Diogo Haussen; Shawna M Cutting; Shelagh B Coutts; Daniel Roy; Jeremy L Rempel; Axel Cr Rohr; Daniela Iancu; Demetrios J Sahlas; Amy Y X Yu; Thomas G Devlin; Ricardo A Hanel; Volker Puetz; Frank L Silver; Bruce C V Campbell; René Chapot; Jeanne Teitelbaum; Jennifer L Mandzia; Timothy J Kleinig; David Turkel-Parrella; Donald Heck; Michael E Kelly; Aditya Bharatha; Oh Young Bang; Ashutosh Jadhav; Rishi Gupta; Donald F Frei; Jason W Tarpley; Cameron G McDougall; Staffan Holmin; Joung-Ho Rha; Ajit S Puri; Marie-Christine Camden; Götz Thomalla; Hana Choe; Stephen J Phillips; Joseph L Schindler; John Thornton; Simon Nagel; Ji Hoe Heo; Sung-Il Sohn; Marios-Nikos Psychogios; Ronald F Budzik; Sidney Starkman; Coleman O Martin; Paul A Burns; Seán Murphy; George A Lopez; Joey English; Michael Tymianski
Journal:  Lancet       Date:  2020-02-20       Impact factor: 79.321

View more
  5 in total

1.  Purinergic Signaling in the Central Nervous System in Health and Disease.

Authors:  Peter Illes; Guang-Yin Xu; Yong Tang
Journal:  Neurosci Bull       Date:  2020-11-04       Impact factor: 5.203

2.  Mitochondrial Events Determine the Status of Hippocampal Cells in the Post-Ischemic Period.

Authors:  Iryna Lushnikova; Yelyzaveta Nikandrova; Galyna Skibo
Journal:  Neurosci Bull       Date:  2021-06-07       Impact factor: 5.271

3.  Neuronal Loss of the Glutamate Transporter GLT-1 Promotes Excitotoxic Injury in the Hippocampus.

Authors:  Theresa S Rimmele; Shaomin Li; Jens Velde Andersen; Emil W Westi; Alexander Rotenberg; Jianlin Wang; Blanca Irene Aldana; Dennis J Selkoe; Chiye J Aoki; Chris G Dulla; Paul Allen Rosenberg
Journal:  Front Cell Neurosci       Date:  2021-12-29       Impact factor: 5.505

4.  Dynamic Alterations of the Gut Microbial Pyrimidine and Purine Metabolism in the Development of Liver Cirrhosis.

Authors:  Yinghui Xiong; Li Wu; Li Shao; Yang Wang; Zebing Huang; Xun Huang; Chunhui Li; Anhua Wu; Zhenguo Liu; Xuegong Fan; Pengcheng Zhou
Journal:  Front Mol Biosci       Date:  2022-01-28

Review 5.  Neuronal Death Mechanisms and Therapeutic Strategy in Ischemic Stroke.

Authors:  Rui Mao; Ningning Zong; Yujie Hu; Ying Chen; Yun Xu
Journal:  Neurosci Bull       Date:  2022-05-05       Impact factor: 5.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.